CDC Notice of Intent to Sole Source for Inhalation Support / TSI MOUDI-II Instrument
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Centers for Disease Control and Prevention (CDC) plans to award a sole-source contract for the purchase of a Micro Orifice Uniform-Deposit Impactor (MOUDI) from TSI Incorporated through simplified acquisition procedures. This procurement is justified because TSI is the only known supplier capable of providing a MOUDI instrument that meets the specific size classification requirements and the uniform sample deposition necessary for inhalation research. The contract will be a total small business set-aside under NAICS code 334516 and will support work to be performed in Morgantown, West Virginia. Interested parties are not being requested to submit competitive quotes, but those who believe they can fulfill the requirement may submit a capability statement by June 17, 2026, for consideration. The notice emphasizes that responding to this announcement does not guarantee the government will initiate a competitive procurement, and any costs incurred by responders will not be reimbursed. Questions and capability statements should be directed via email to the designated contract specialist, Aminah Gary, at the provided contact information. The decision to proceed with this sole-source acquisition rests solely with the government, which will use any received information to determine if competition is warranted. The solicitation number for this procurement is 75D301-26-Q-98063, and the official posting date is June 10, 2026.
General Info
Agency
NAICS
Place of Performance
Morgantown, WV, USASet-Aside
Timeline
Response Deadline
Organization & Contact Information
Full Description
This is a notice of intent to award a sole-source contract using simplified acquisition procedures and is not a request for competitive quotes.
The Centers for Disease Control and Prevention (CDC) intends to award a sole-source purchase order using the procedures at RFO 12.102(a) as it has been deemed that only one source is available to meet this specific requirement due to the intended vendor, TSI Incorporated being the only company making a Micro Orifice Uniform-Deposit Impactors (MOUDI) that meets the wide range of size classification, and the ability to deposit the samples uniformly for inhalation research. The statement of work and specifications are attached.
This notice of intent is not a request for competitive quotations. Any party who believes they can perform this requirement should submit a capability statement for consideration by the government. A determination by the government not to compete this proposed contract based on responses to this notice is solely within the discretion of the government. Information received by the government as a result of this notice will be considered solely for the purpose of determining whether to conduct competitive procurement.
The government will not be responsible for any costs incurred by a party who responds to this notice. A party may identify their interest and submit a capability statement by 4pm (EST) on 17 June 2026.
Responses, including questions about this notice, should be sent via email to Contract Specialist, Aminah Gary at uuu0@cdc.gov
